share_log

NexImmune Analyst Ratings

Benzinga Analyst Ratings ·  Nov 16, 2022 20:31
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/16/2022 Cantor Fitzgerald Downgrades Overweight → Neutral
11/15/2022 Raymond James Downgrades Outperform → Market Perform
08/16/2022 339.66% Barclays $7 → $2 Maintains Overweight
08/16/2022 559.49% Raymond James $12 → $3 Maintains Outperform
06/01/2022 999.14% BTIG → $5 Initiates Coverage On → Buy
04/01/2022 1438.8% Barclays $4 → $7 Maintains Overweight
02/22/2022 2757.77% Raymond James $21 → $13 Maintains Outperform
11/15/2021 4516.4% Raymond James $30 → $21 Maintains Outperform
04/01/2021 6494.86% Raymond James → $30 Initiates Coverage On → Outperform
03/09/2021 7594% Cantor Fitzgerald → $35 Initiates Coverage On → Overweight

What is the target price for NexImmune (NEXI)?

The latest price target for NexImmune (NASDAQ: NEXI) was reported by Cantor Fitzgerald on November 16, 2022. The analyst firm set a price target for $0.00 expecting NEXI to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for NexImmune (NEXI)?

The latest analyst rating for NexImmune (NASDAQ: NEXI) was provided by Cantor Fitzgerald, and NexImmune downgraded their neutral rating.

When is the next analyst rating going to be posted or updated for NexImmune (NEXI)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NexImmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NexImmune was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.

Is the Analyst Rating NexImmune (NEXI) correct?

While ratings are subjective and will change, the latest NexImmune (NEXI) rating was a downgraded with a price target of $0.00 to $0.00. The current price NexImmune (NEXI) is trading at is $0.45, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment